基于治疗药物监测的丹麦儿科患者中佩拉曼奈尔的药理动力学
Sara Angelucci1,2, Morten Baltzer Houlind3,4, Maja Stjerne Hansen5
1Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Basic & clinical pharmacology & toxicology
|February 8, 2026
概括
在儿童和青少年中,血清佩拉曼尼尔度有显著的变化,影响剂量. 治疗药物监测 (TDM) 有助于优化佩拉曼尼尔剂量以控制发作,但不能预测发作自由度或副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 儿科神经学 儿科神经学
背景情况:
- 佩拉曼奈尔是一种用于小儿的抗发作药物 (ASM).
- 了解佩拉曼奈尔血清度的变化对于有效治疗至关重要.
- 在perampanel水平的患者间和患者内变化可能会影响治疗结果.
研究的目的:
- 为了量化血清佩拉曼奈尔度的患者间和患者内变异性.
- 评估佩拉曼尼尔度对儿科患者治疗疗效和耐受性的预测价值.
- 为了确定影响佩拉曼奈尔药理动学的因素,如年龄和并发药物.
主要方法:
- 在68名儿童和青少年 (<18岁) 中进行了回顾性队列研究,这些儿童和青少年接受了帕拉曼内尔治疗.
- 对311个治疗药物监测 (TDM) 样本的分析.
- 根据年龄组和并发药物类别 (诱导酶的ASM,氨酸,非诱导ASM) 评估剂量正常化度比 (C: D/kg).
主要成果:
- 在13.8%的样本中,香的度超出了推的治疗范围.
- 在患者之间观察到C: (((D/kg) 的59.2倍变化.
- 年龄较小的儿童 (<6岁) 的度低于年龄较大的青少年 (>12岁).
- 诱导酶的ASM显著降低了C:
- 虽然80.9%的患者出现了减轻发作负担,而20.6%的患者实现了无发作,但血清度与这些结果或不良反应没有相关性.
结论:
- 治疗药物监测 (TDM) 对于识别儿科患者中佩拉曼内尔剂量不足或过量的治疗是有价值的.
- 与年龄相关的清除变化和诱导酶的共用药物显著影响香的度.
- 虽然血清度可以指导剂量调整,但优化应侧重于临床发作减少和耐受性.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
248
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
248
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
274
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
326
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
326
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
242
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
242
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
212
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
212
01:16Therapeutic Drug Monitoring: Overview and Classification
359
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
359